WHC is still in active development. Read this to understand our approach.
depiction of BOOQTIHIKDDPRW-UHFFFAOYSA-N.svg
tripsit

dpt

Verificar en tripsit

psychonaut

DPT

Verificar en psychonaut

isomerdesign

DPT

Verificar en isomerdesign

druglab

DPT

Verificar en druglab

wiki

Dipropyltryptamine

Verificar en wiki

Data

InChI: InChI=1S/C16H24N2/c1-3-10-18(11-4-2)12-9-14-13-17-16-8-6-5-7-15(14)16/h5-8,13,17H,3-4,9-12H2,1-2H3

Sinónimos: N-[2-(1H-Indol-3-yl)ethyl]-N-propylpropan-1-amine,SCHEMBL1118996,DPT,BRN 0173122,3-[2-(Dipropylamino)ethyl]indole,INDOLE, 3-(2-(DIPROPYLAMINO)ETHYL)-,N,N-Dipropyltryptamine(DPT),Indole, 3-[2-(dipropylamino)ethyl],N,N-Dipropyltryptamine, free base,C16086,MB02028,ADAL1292863,DPT [Experimental Drug],N-[2-(1H-indol-3-yl)ethyl]-N-propylpropan-1-amine,AKOS015967123,Tryptamine, N,N-dipropyl,4-22-00-04323 (Beilstein Handbook Reference),N,N-Dipropyltryptamine,FT-0629586,1H-Indole-3-ethanamine, N,N-dipropyl-,61-52-9,[2-(1H-indol-3-yl)ethyl]dipropylamine,S7272VWU50,DTXSID30209847,3-(2-(Dipropylamino)ethyl)indole,DB-023078,A833279,NCGC00247727-01,Q2723010,dipropyltryptamine,Dipropyltryptamine,N-[2-(1H-indol-3-yl)ethyl]-N-propyl-propan-1-amine,CHEMBL1779153,N-(2-(1H-indol-3-yl)ethyl)-N-propylpropan-1-amine,D-6500,UNII-S7272VWU50

Estimated data

Solubilidad: -2.6 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)

Addictivity Prediction: 94.2% (prediction based on www.mdpi.com)

Similitudes

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.